STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] METLIFE INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

MetLife, Inc. reported a change in beneficial ownership. The Board of Directors, as an entity, filed an amended Schedule 13D noting beneficial ownership of 106,549,803 shares of common stock, representing 16.17% of the class as of October 31, 2025. The Board has shared voting power over 106,549,803 shares and no sole voting or dispositive power.

The shares are held by the MetLife Policyholder Trust, originally issued 494,466,664 shares in 2000 under the demutualization plan. The Trustee votes per Board recommendations on most matters; on specified Beneficiary Consent Matters, votes are cast in proportion to beneficiary instructions. Since July 31, 2025, Trust holdings decreased from 108,242,821 to 106,549,803 due to beneficiary transactions and withdrawals under the Plan and Trust Agreement. Beneficiaries have rights to dividends and sale proceeds on their allocated shares.

Positive
  • None.
Negative
  • None.

Insights

Neutral update: Board reports 16.17% beneficial stake via Trust.

The filing states the Board of Directors is deemed to beneficially own 106,549,803 shares of MetLife common stock, equal to 16.17% as of October 31, 2025. Voting power is shared for the same number of shares, with no sole voting or dispositive power.

These shares reside in the MetLife Policyholder Trust created in the demutualization. The Trustee generally votes per Board recommendations, while Beneficiary Consent Matters are voted proportionally to beneficiary instructions. Beneficiaries can withdraw allocated shares and receive dividends and sale proceeds.

The position fell from 108,242,821 to 106,549,803 since July 31, 2025, reflecting beneficiary-driven activity permitted by the Plan. The update is administrative; actual impact depends on trustee voting mechanics and beneficiary actions.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
*Unless otherwise indicated, all information relating to beneficial ownership of Shares by the Reporting Persons is as of October 31, 2025.


SCHEDULE 13D


Board of Directors of MetLife, Inc., as an entity
Signature:*
Name/Title:Carlos M. Gutierrez
Date:11/06/2025
Signature:*
Name/Title:Carla A. Harris
Date:11/06/2025
Signature:*
Name/Title:Laura J. Hay
Date:11/06/2025
Signature:*
Name/Title:R. Glenn Hubbard
Date:11/06/2025
Signature:*
Name/Title:Jeh C. Johnson
Date:11/06/2025
Signature:*
Name/Title:William E. Kennard
Date:11/06/2025
Signature:*
Name/Title:Michel A. Khalaf
Date:11/06/2025
Signature:*
Name/Title:Diana L. McKenzie
Date:11/06/2025
Signature:*
Name/Title:Denise M. Morrison
Date:11/06/2025
Signature:*
Name/Title:Christian Mumenthaler
Date:11/06/2025
Signature:*
Name/Title:Mark A. Weinberger
Date:11/06/2025
Comments accompanying signature:
*By /s/ John A. Hall John A. Hall Attorney-in-fact

FAQ

What beneficial ownership did MET's Board report in this amendment?

The Board reported beneficial ownership of 106,549,803 shares, representing 16.17% of MetLife's common stock as of October 31, 2025.

How much voting power does the Board have over MET shares?

The Board has shared voting power over 106,549,803 shares and no sole voting or dispositive power.

Why does the Board report this stake if shares are in a trust?

The shares are held by the MetLife Policyholder Trust, and the Board is deemed a beneficial owner because the Trustee votes per Board recommendations except on defined Beneficiary Consent Matters.

What changed in the Trust's holdings recently for MET?

Since July 31, 2025, Trust holdings decreased from 108,242,821 to 106,549,803 due to beneficiary transactions and withdrawals under the Plan.

Who receives dividends on the MET shares in the Trust?

The Beneficiaries of the Trust have the right to receive dividends and sale proceeds on their allocated shares.

How are Beneficiary Consent Matters voted for MET?

On Beneficiary Consent Matters, the Trustee votes all shares in the same ratio as beneficiary voting instructions returned to the Trustee.
MetLife

NYSE:MET

MET Rankings

MET Latest News

MET Latest SEC Filings

MET Stock Data

52.32B
663.27M
0.25%
91.63%
1.37%
Insurance - Life
Life Insurance
Link
United States
NEW YORK